Bath & Body Works (NYSE:BBWI) Trading 3.3% Higher – Time to Buy?

Shares of Bath & Body Works, Inc. (NYSE:BBWI) were up 3.3% during trading on Monday . The stock traded as high as $20.45 and last traded at $20.4450. Approximately 4,271,007 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 6,043,855 shares. The stock had previously closed at $19.79.

Analysts Set New Price Targets

A number of research analysts have issued reports on BBWI shares. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $38.00 to $17.00 in a report on Friday, November 21st. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, November 21st. Morgan Stanley restated an “equal weight” rating and issued a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. Barclays decreased their price objective on shares of Bath & Body Works from $28.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Friday, November 21st. Finally, UBS Group cut their target price on shares of Bath & Body Works from $32.00 to $17.00 and set a “neutral” rating for the company in a research note on Friday, November 21st. Five equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $23.61.

Bath & Body Works Stock Performance

The stock has a market cap of $4.20 billion, a P/E ratio of 6.31, a PEG ratio of 0.73 and a beta of 1.51. The firm’s 50-day moving average is $21.06 and its two-hundred day moving average is $26.15.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. The company’s revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Friday, November 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.9%. Bath & Body Works’s dividend payout ratio (DPR) is currently 24.62%.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, Director Steven E. Voskuil acquired 20,000 shares of the stock in a transaction dated Friday, November 21st. The shares were bought at an average cost of $15.04 per share, for a total transaction of $300,800.00. Following the completion of the acquisition, the director directly owned 33,925 shares of the company’s stock, valued at approximately $510,232. This trade represents a 143.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen D. Steinour purchased 6,700 shares of the business’s stock in a transaction on Friday, November 21st. The shares were acquired at an average cost of $14.86 per share, for a total transaction of $99,562.00. Following the completion of the transaction, the director directly owned 48,175 shares in the company, valued at approximately $715,880.50. This represents a 16.15% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 33,513 shares of company stock worth $500,442. Insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the stock. Stonehage Fleming Financial Services Holdings Ltd bought a new position in Bath & Body Works in the 2nd quarter valued at about $33,000. First Horizon Corp bought a new position in shares of Bath & Body Works in the 3rd quarter valued at $29,000. Geneos Wealth Management Inc. lifted its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the last quarter. Parallel Advisors LLC grew its position in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after acquiring an additional 481 shares during the last quarter. Finally, Danske Bank A S acquired a new position in Bath & Body Works during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.